News

Fierce Pharma1d
RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance
A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...
New Atlas3d
Over 60s get long-term protection against RSV from single shot
A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...
Infectious Disease Advisor8h
Severity of RSV Disease in Infants Can Be Effectively Monitored With CPS-Ped
The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.
Single-dose vaccine demonstrates sustained efficacy against RSV-related lower respiratory tract disease in older adults
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...
A parent’s worst nightmare: RSV
Although we can’t control what others chose to do about handwashing and social distancing, we can decide to protect our ...
The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months
The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results of ziresovir, a novel RSV-targeted ...
Number of Queensland babies hospitalised with respiratory illness down 70pc since RSV jab released
One less infant, under the age of six months, was hospitalised each day following the release of the Respiratory Syncytial ...
Healio5d
RSV triples a person’s risk for death within 1 year, study shows
After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...